Partial clinical remission in type 1 diabetes: a comparison of the accuracy of total daily dose of insulin of <0.3 units/kg/day to the gold standard insulin-dose adjusted hemoglobin A1c of ≤9 for the detection of partial clinical remission

Authors:
  • RLRachel L. Lundberg
    Rachel L. Lundberg
  • KMKatherine R. Marino
    Katherine R. Marino
  • AJAastha Jasrotia
    Aastha Jasrotia
  • LMLouise S. Maranda
    Louise S. Maranda
  • BBBruce A. Barton
    Bruce A. Barton
  • LALaura C. Alonso
    Laura C. Alonso

Abstract
Background: It is unclear whether the gold standard test for the detection of partial clinical remission (PCR) in new-onset type 1 diabetes (T1D), the insulin-dose adjusted Hemoglobin AMethods: A retrospective analysis of 204 subjects of ages 2–14 years, mean age 7.9±3.2 years, (male 7.8±3.4 years, [n=98]; female 7.9±3.0 years, [n=106], p=0.816) with new-onset T1D. Anthropometric and biochemical data were collected for the first 36 months of disease. PCR was defined by both IDAAResults: There were 86 (42.2%) (age 9.1±3.0 years; male 57%) remitters by IDAAConclusions: There were no significant differences in the number of remitters, duration of PCR, or the time of peak remission defined by IDAA

This publication has 29 references indexed in Scilit: